(Q34305225)

1 August 2017

1 reference

title

Immunity to oncogenic human papillomaviruses (English)

1 reference

1 August 2017

Konya J

1

1 reference

PubMed ID

11447764

1 August 2017

Dillner J

series ordinal

2

1 reference

1 August 2017

1 January 2001

1 reference

Advances in Cancer Research

1 August 2017

1 reference

1 August 2017

82

1 reference

1 August 2017

205-238

1 reference

Stability over time of serum antibody levels to human papillomavirus type 16.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

No serological evidence for non-sexual spread of HPV16

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured normal human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Langerhans cells in human warts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Cytokine Dysregulation in Invasive Cervical Carcinoma and Other Human Neoplasias: Time to Consider the TH1/TH2 Paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Loss of MHC class-I expression in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Effect of HIV infection on the natural history of anal human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Activation of naive, memory and effector T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA-DQB1*03 and cervical intraepithelial neoplasia type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

The serological response to papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

High risk genital papillomavirus infections are not spread vertically

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Human papillomavirus infection is transient in young women: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

The Sexually Transmitted Disease Model for Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Transmission of Cervical Human Papillomavirus Infection by Sexual Activity: Differences between Low and High Oncogenic Risk Types

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA antigens and cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Sequences and factors: a guide to MHC class-II transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with theHLA-DQA1*0102-DQB1*0602 haplotype: A population-based case–control study of Norwegian women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Determinants of genital human papillomavirus infection in low-income women in Washington, D.C.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA and susceptibility to cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Human T helper cell epitopes overlap B cell and putative cytotoxic T cell epitopes in the E2 protein of human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Cervical cancer as an AIDS-defining illness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Expression of Intercellular Adhesion Molecule-1 (ICAM-1) in the Skin of Patients with Systemic Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Relationship between types of human papillomavirus and Langerhans' cells in cervical condyloma and intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Papillomavirus is resistant to desiccation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Distribution of HLA class II alleles among Norwegian Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Decreased frequency of HLA-DRB 1*13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Palate structure in human holoprosencephaly correlates with the facial malformation and demonstrates a new palatal developmental field

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Regression of plane warts following spontaneous inflammation. An histopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

The cellular immune response to human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Langerhans cells, inflammation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Epithelial expression of HLA-DR antigens in laryngeal papillomas with a dense inflammatory reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Identification of human papillomavirus seroconversions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2801%2982007-8

7 January 2021

10.1016/S0065-230X(01)82007-8

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11447764